Information:
Fel:
ID
43950
Beskrivning
A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.; ODM derived from: https://clinicaltrials.gov/show/NCT00517699
Länk
https://clinicaltrials.gov/show/NCT00517699
Nyckelord
Versioner (3)
- 2017-06-29 2017-06-29 -
- 2017-07-03 2017-07-03 - Julian Varghese
- 2021-09-20 2021-09-20 -
Uppladdad den
20 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Lymphoma NCT00517699
Eligibility Lymphoma NCT00517699
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT00517699
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
adult patients, 18-80 years of age;
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
histological diagnosis of primary central nervous system lymphoma;
boolean
C0280803 (UMLS CUI [1])
ID.3
Item
b-cell proliferation verified by positive staining for cd20;
boolean
C1155008 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C3888518 (UMLS CUI [1,2])
ID.4
Item
>=1 measurable lesion.
boolean
C0221198 (UMLS CUI [1])
ID.5
Item
prior chemotherapy, other than corticosteroids, >=6 weeks before and after diagnosis or surgery;
boolean
C0392920 (UMLS CUI [1])
ID.6
Item
history of prior cranial irradiation;
boolean
C0079172 (UMLS CUI [1])
non hodgkin lymphoma
Item
evidence of plurisystemic non-hodgkin's lymphoma;
boolean
C0024305 (UMLS CUI [1])
ID.8
Item
other active malignant disease (other than basal cell or squamous cell cancer of skin,or cancer in situ of cervix;
boolean
C0012634 (UMLS CUI [1])
ID.9
Item
uncontrolled active infection.
boolean
C3714514 (UMLS CUI [1])